Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by 1998novlon Sep 29, 2020 10:11am
145 Views
Post# 31634544

RE:RE:RE:Different leadership, same old Theratechnologies

RE:RE:RE:Different leadership, same old TheratechnologiesI guess I actually think they are doing a lot of things right. Where many are looking to blame someone or something I appreciate the positives, like how they paid $1millikn for Trogarzo and turned the company around.  I thought Tanguay was excellent. Happy to have Paul on board to take it to the next level. As I've said many times before this is more of a small cap market phenomenon than anything else. To this extent I think the only thing the company could do is show some immediate value by partnering and getting a bigger player to take an equity stake. This is how most of the small caps eventually break out of their misery. Regardless, in my opinion I think these are company decisions and not mine. I'll end on this note, go look back at any small cap pharma stock that had a good run and watch how quickly the stock became a 5 bagger. And then ask yourself how all of those companies felt prior to their stock going up? I would guess the same how TH mgmt feels now.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse